Previous Close | 22.62 |
Open | 22.37 |
Bid | 22.66 x 0 |
Ask | 22.72 x 0 |
Day's Range | 22.37 - 22.37 |
52 Week Range | 22.37 - 31.03 |
Volume | |
Avg. Volume | 0 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
On September 13, 2024, Director Katherine Doyle sold 8,954 shares of Perrigo Co PLC (NYSE:PRGO) as reported in a recent SEC Filing.
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here. Major index returns increased in the quarter due to strong earnings from large-cap technology companies, especially those connected to artificial intelligence. However, the market’s breadth revealed a different picture. The […]
We recently compiled a list of the 10 Best Mid-Cap Healthcare Stocks To Buy Now. In this article, we are going to take a look at where Perrigo Company plc (NYSE:PRGO) stands against the other mid-cap healthcare stocks. Global Healthcare Market: Growth Projections, Challenges, and Tech-Driven Innovations According to projections by ReportLinker, the market for healthcare […]